Ledger.Open graph →
SEC Form D · Amendment · filed December 11, 2017

Paradigm Diagnostics, Inc

Offering
$9.0M
Sold
$7.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
PHOENIX, AZ
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Robert Armknecht · PHOENIX, AZDirectorErin Curley · PHOENIX, AZDirectorGrace Colon · PHOENIX, AZDirectorDavid Mallery · PHOENIX, AZExec · DirectorDavid Neal · PHOENIX, AZExecCarey Ng · PHOENIX, AZDirectorScott Morris · PHOENIX, AZExecKevin M. Rendino · Montclair, NJExec · DirectorRobert Rigdon · HOUSTON, TXExecReeve Waud · CHICAGO, ILDirectorLorenzo Lamadrid · HOUSTON, TXDirectorDean Thrasher · Wakefield, MADirectorNicole S. Goncalves-Krysinski · Vancouver, British Columbia, CanadaDirectorDavid Hiscocks · HOUSTON, TXExec · DirectorDuane A. Sartori · Santa Rosa, CADirectorAlex Tkachenko · San Francisco, CAExecDenis Slavich · HOUSTON, TXDirectorAjaib Bhadare · Santa Rosa, CAExecGiles Carmichael · New York, NYDirectorPeter H. Chou · SARATOGA, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗